Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. PURPOSE: This randomized phase I trial is studying the side effects and best dose of photodynamic therapy in treating patients with premalignant or early stage head and neck tumors.
Epistemonikos ID: 5bfa13924c2b1f00c1eaa79d80488ed2e7745379
First added on: May 05, 2024